$$\rightleftharpoonup{xx}$$
$$\longleftharp{xx}$$,
$$\longrightharp{xx}$$,
The field of proteomics has been revolutionized by the widespread adoption of open-access data repositories and free software tools1, which have been instrumental in advancing research capabilities and promoting a culture of data sharing. The establishment of centralized resources, such as PRIDE2, and the development of standardized data formats by the Human Proteome Organization (HUPO) Proteomics Standards Initiative (PSI)3 have created an unprecedented opportunity for data reuse and integration. However, the analysis and interpretation of proteomic data still present significant technical barriers, particularly for biologists and physician scientists who wish to perform orthogonal validation of their own experimental results4. This manuscript directly addresses this challenge by presenting a vendor-agnostic computational workflow to provide an accessible framework for researchers to independently query, analyze, and integrate public proteomics data with their own findings, thereby facilitating robust orthogonal validation without the need for additional wet-lab experiments. This work is particularly appropriate for researchers seeking to orthogonally validate the differential expression of specific proteins identified in their own experiments and generate novel hypotheses by exploring the expression patterns of their proteins of interest across a wide range of published studies. By providing a step-by-step guide, we aim to empower a wider range of scientists to harness the full potential of public proteomics data, ultimately enhancing the robustness and impact of their research.
In mass spectrometry (MS)-based proteomics, MS1 and MS2 scans are fundamental to data acquisition. MS1 scans, or survey scans, detect and measure the mass-to-charge (m/z) ratios of all ions in a sample, providing a comprehensive overview of the ion population5. MS2 scans, also called fragmentation scans, involve isolating and fragmenting specific precursor ions chosen from the MS1 scan, generating fragment ion spectra for peptide identification6.
Data-dependent acquisition (DDA) selects the most abundant ions from MS1 scans for MS2 fragmentation, producing simpler spectra that streamline analysis. However, DDA can lead to stochastic sampling and missing values in complex samples, limiting reproducibility7. In contrast, data-independent acquisition (DIA) systematically fragments all ions within predefined m/z windows, ensuring comprehensive coverage and minimizing missing values. This enhances quantitative accuracy and reproducibility8, though DIA demands advanced computational tools to deconvolve its highly complex MS2 spectra9.
PRIDE (https://www.ebi.ac.uk/pride)2i s a leading repository within the ProteomeXchange Consortium (https://www.proteomexchange.org)10, a global platform for sharing proteomics data. Users can efficiently navigate this vast resource using keyword searches to locate datasets of interest.
DIA-NN11, a software suite leveraging deep neural networks, is a gold-standard tool for analyzing data-independent acquisition (DIA) proteomics data. It excels in identification and quantification accuracy, making it particularly effective for processing complex DIA datasets12. For data-dependent acquisition (DDA) workflows, MSFragger13, integrated into the FragPipe pipeline, offers ultrafast peptide identification. Its innovative fragment-ion indexing approach enables rapid spectral matching, outperforming traditional tools by over 100-fold in speed.
Equipped with these comprehensive databases and advanced tools, researchers can readily reuse proteomic data for cross-study validation and novel biological discoveries. This accessibility has driven the identification of numerous protein biomarkers across diverse diseases14,15, improved prognosis prediction16, and enabled molecular subtype classification based on proteomic profiles17.